On Monday, August 4, the next meeting of the Transparency Council.
Iwona Schymalla's guest is Dr. Krzysztof Dyrbuś, a cardiologist from the Silesian Center for Heart Diseases in Zabrze.
It will be the first and only molecularly targeted therapy in Europe for the treatment of diffuse glioblastoma grade II, with IDH (isocitrate dehydrogenase) gene mutations. What drug is involved?
On Monday, July 28, the next meeting of the Transparency Council.
National Drug Manufacturers appreciates the contribution of Minister Izabela Leszczyna and the entire leadership and team of the ministry to building Poland's drug security, and hopes that these activities will be continued by the new Minister Jolanta Sobieranska-Grenda.
Wednesday, July 23, is the next meeting of the Transparency Council.
On Monday, July 21, the next meeting of the Transparency Council.
In the face of growing challenges to drug availability in Europe, the Health Ministry has presented a new, expanded version of the National List of Critical Medicines. The document, which is crucial to securing the health needs of Poles, now includes 401 active substances - more than a hundred...
The Health Ministry is analyzing several hundred comments submitted during public consultations on the draft amendment to the Reimbursement Act and assumes that the draft will go to the Parliament soon after the parliamentary vacations. The changes concern, among other things, drug programs.
On Monday, July 14, the next meeting of the AOTMiT Transparency Council.
Anna Gruszczak, MD, from the Department of Neurology, National Medical Institute of the Ministry of Internal Medicine, talks about the first therapeutic breakthrough for ALS patients.
On Monday, July 7, the next meeting of the AOTMiT Transparency Council.
Ministerstwo Zdrowia opublikowało zaktualizowaną listę leków, środków specjalnego przeznaczenia żywieniowego i wyrobów medycznych, których może zabraknąć w polskich aptekach. Wykaz obowiązuje od 10 lipca 2025 roku.
An interview with Prof. Karina Jahnz-Różyk, national consultant in allergology and head of the Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases at the Military Medical Institute in Warsaw.
The Health Ministry publishes an announcement from the Minister of Health regarding medicinal products not subject to financing under the procedure for emergency access to drug technologies.
On Monday, June 30, the next meeting of the Transparency Council.
- Thanks to innovative drugs, we can treat effectively with fewer visits, which means not only convenience for patients, but also real savings for the system," says Professor Robert Rejdak, head of the Department of General Ophthalmology and the Department of Ophthalmology at the Medical...
The Health Ministry has published a list of technologies with a high level of innovation.
Amyotrophic lateral sclerosis (ALS) is a severe and rapidly progressive disease with which patients live an average of 3 to 5 years. Diagnosis is a veritable odyssey, taking up to several years. Now, as never before, genetic testing is becoming crucial, as the world's first therapy has been...
The Health Ministry summarizes the July reimbursement announcement. What news for patients?
On June 12, 2025, during the General Meeting of the Association of Employers of Innovative Pharmaceutical Companies INFARMA, a new Board of Directors and Supervisory Board were elected for another 3-year term. Wiktor Janicki, President of the Management Board of AstraZeneca Pharma Poland, was...
W poniedziałek 16 czerwca kolejne posiedzenie Rady Przejrzystości.
- This is a huge success of the Polish government, which under our presidency led to a compromise among member states on the biggest reform of EU pharmaceutical law in 20 years. We supported these measures in the European forum, because they were aimed at shortening the monopoly of medicines and...
The Health Minister has announced a great success for the Polish Presidency of the EU Council. Member states have adopted a compromise on the so-called pharmaceutical package. The reform means improved access to both innovative and generic drugs.
On Monday, June 9, the next meeting of the AOTMiT Transparency Council.
Główny Inspektor Farmaceutyczny wstrzymał obrót jedną z serii szczepionki przeciw ospie wietrznej.
On Monday, June 2, the next meeting of the Transparency Council.
The draft amendment to the Reimbursement Act is an important step by the Health Ministry to improve the availability of medicines for patients and improve the operation of the pharmaceutical market in Poland. Entrepreneurs producing drugs in the country appreciate the increasing quality of...
- Restricting access to spinal cord stimulators can not only promote opioid addiction, but also exclude thousands of patients from professional and social life, says Professor Tomasz Mandat, head of the Nervous System Tumor Clinic at the National Cancer Institute.
The subcutaneous drug is administered in seconds once every two weeks. Lives change, parents return to work, children forget about the disease, they say they have regained their lives anew," says Ewelina Matuszak, president of the Sanguis Foundation - Hemophilia and Related Hemorrhagic Diathesis,...
© 2023 Medexpress. All Rights Reserved
